363 related articles for article (PubMed ID: 12923563)
1. The alphavbeta5 integrin of hematopoietic and nonhematopoietic cells is a transduction receptor of RGD-4C fiber-modified adenoviruses.
Nagel H; Maag S; Tassis A; Nestlé FO; Greber UF; Hemmi S
Gene Ther; 2003 Sep; 10(19):1643-53. PubMed ID: 12923563
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus type 5 uptake by lung adenocarcinoma cells in culture correlates with Ad5 fibre binding is mediated by alpha(v)beta1 integrin and can be modulated by changes in beta1 integrin function.
Davison E; Kirby I; Whitehouse J; Hart I; Marshall JF; Santis G
J Gene Med; 2001; 3(6):550-9. PubMed ID: 11778901
[TBL] [Abstract][Full Text] [Related]
3. Fiber-modified adenovirus vectors containing the TAT peptide derived from HIV-1 in the fiber knob have efficient gene transfer activity.
Kurachi S; Tashiro K; Sakurai F; Sakurai H; Kawabata K; Yayama K; Okamoto H; Nakagawa S; Mizuguchi H
Gene Ther; 2007 Aug; 14(15):1160-5. PubMed ID: 17508008
[TBL] [Abstract][Full Text] [Related]
4. Porcine adenovirus serotype 3 internalization is independent of CAR and alphavbeta3 or alphavbeta5 integrin.
Bangari DS; Mittal SK
Virology; 2005 Feb; 332(1):157-66. PubMed ID: 15661148
[TBL] [Abstract][Full Text] [Related]
5. CAR- or alphav integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice.
Mizuguchi H; Koizumi N; Hosono T; Ishii-Watabe A; Uchida E; Utoguchi N; Watanabe Y; Hayakawa T
Gene Ther; 2002 Jun; 9(12):769-76. PubMed ID: 12040458
[TBL] [Abstract][Full Text] [Related]
6. Adenoviral gene therapy for renal cancer requires retargeting to alternative cellular receptors.
Haviv YS; Blackwell JL; Kanerva A; Nagi P; Krasnykh V; Dmitriev I; Wang M; Naito S; Lei X; Hemminki A; Carey D; Curiel DT
Cancer Res; 2002 Aug; 62(15):4273-81. PubMed ID: 12154029
[TBL] [Abstract][Full Text] [Related]
7. Combined targeting of adenoviruses to integrins and epidermal growth factor receptors increases gene transfer into primary glioma cells and spheroids.
Grill J; Van Beusechem VW; Van Der Valk P; Dirven CM; Leonhart A; Pherai DS; Haisma HJ; Pinedo HM; Curiel DT; Gerritsen WR
Clin Cancer Res; 2001 Mar; 7(3):641-50. PubMed ID: 11297260
[TBL] [Abstract][Full Text] [Related]
8. Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors.
Wesseling JG; Bosma PJ; Krasnykh V; Kashentseva EA; Blackwell JL; Reynolds PN; Li H; Parameshwar M; Vickers SM; Jaffee EM; Huibregtse K; Curiel DT; Dmitriev I
Gene Ther; 2001 Jul; 8(13):969-76. PubMed ID: 11438831
[TBL] [Abstract][Full Text] [Related]
9. Coxsackie adenovirus receptor and alpha nu beta3/alpha nu beta5 integrins in adenovirus gene transfer of rat cochlea.
Venail F; Wang J; Ruel J; Ballana E; Rebillard G; Eybalin M; Arbones M; Bosch A; Puel JL
Gene Ther; 2007 Jan; 14(1):30-7. PubMed ID: 16886000
[TBL] [Abstract][Full Text] [Related]
10. Human hematopoietic (CD34+) stem cells possess high-affinity receptors for adenovirus type 11p.
Mei YF; Segerman A; Lindman K; Hörnsten P; Wahlin A; Wadell G
Virology; 2004 Oct; 328(2):198-207. PubMed ID: 15464840
[TBL] [Abstract][Full Text] [Related]
11. Melanoma cultures show different susceptibility towards E1A-, E1B-19 kDa- and fiber-modified replication-competent adenoviruses.
Schmitz M; Graf C; Gut T; Sirena D; Peter I; Dummer R; Greber UF; Hemmi S
Gene Ther; 2006 Jun; 13(11):893-905. PubMed ID: 16482201
[TBL] [Abstract][Full Text] [Related]
12. Interaction of penton base Arg-Gly-Asp motifs with integrins is crucial for adenovirus serotype 35 vector transduction in human hematopoietic cells.
Murakami S; Sakurai F; Kawabata K; Okada N; Fujita T; Yamamoto A; Hayakawa T; Mizuguchi H
Gene Ther; 2007 Nov; 14(21):1525-33. PubMed ID: 17805302
[TBL] [Abstract][Full Text] [Related]
13. Reducing the native tropism of adenovirus vectors requires removal of both CAR and integrin interactions.
Einfeld DA; Schroeder R; Roelvink PW; Lizonova A; King CR; Kovesdi I; Wickham TJ
J Virol; 2001 Dec; 75(23):11284-91. PubMed ID: 11689608
[TBL] [Abstract][Full Text] [Related]
14. Reduction of natural adenovirus tropism to mouse liver by fiber-shaft exchange in combination with both CAR- and alphav integrin-binding ablation.
Koizumi N; Mizuguchi H; Sakurai F; Yamaguchi T; Watanabe Y; Hayakawa T
J Virol; 2003 Dec; 77(24):13062-72. PubMed ID: 14645563
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of the coxsackie and adenovirus receptor downregulates αvβ3 and αvβ5 integrin expression and reduces cell adhesion and migration.
Majhen D; Stojanović N; Špeljko T; Brozovic A; De Zan T; Osmak M; Ambriović-Ristov A
Life Sci; 2011 Aug; 89(7-8):241-9. PubMed ID: 21712047
[TBL] [Abstract][Full Text] [Related]
16. CAR is a cell-cell adhesion protein in human cancer cells and is expressionally modulated by dexamethasone, TNFalpha, and TGFbeta.
Brüning A; Runnebaum IB
Gene Ther; 2003 Feb; 10(3):198-205. PubMed ID: 12571626
[TBL] [Abstract][Full Text] [Related]
17. Identification of HI-like loop in CELO adenovirus fiber for incorporation of receptor binding motifs.
Logunov DY; Zubkova OV; Karyagina-Zhulina AS; Shuvalova EA; Karpov AP; Shmarov MM; Tutykhina IL; Alyapkina YS; Grezina NM; Zinovieva NA; Ernst LK; Gintsburg AL; Naroditsky BS
J Virol; 2007 Sep; 81(18):9641-52. PubMed ID: 17596306
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of transfection rates on head and neck squamous cell cancer by a novel adenovirus: an in vivo and in vitro study.
Lalonde ES; Beyer G; Friedlander PL; Kolls JK
Head Neck; 2002 Dec; 24(12):1038-46. PubMed ID: 12454941
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the efficiency of transduction of leukemic cells by fiber-modified adenoviruses.
Yotnda P; Zompeta C; Heslop HE; Andreeff M; Brenner MK; Marini F
Hum Gene Ther; 2004 Dec; 15(12):1229-42. PubMed ID: 15684699
[TBL] [Abstract][Full Text] [Related]
20. Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers.
Fechner H; Haack A; Wang H; Wang X; Eizema K; Pauschinger M; Schoemaker R; Veghel R; Houtsmuller A; Schultheiss HP; Lamers J; Poller W
Gene Ther; 1999 Sep; 6(9):1520-35. PubMed ID: 10490761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
